Mouse PD-1 Antibody AF1021: R&D Systems
Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo | Nature Biotechnology
Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells | Clinical Cancer Research
Frontiers | Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors | Cell and Developmental Biology
Human PD-1 Antibody (PD1.D3), mAb, Mouse - GenScript
The FG Loop of PD-1 Serves as a “Hotspot” for Therapeutic Monoclonal Antibodies in Tumor Immune Checkpoint Therapy - ScienceDirect
Bio X Cell - InVivoMAb anti-mouse PD-1 (CD279)
Selective HDAC6 inhibitors improve anti-PD-1 immune checkpoint blockade therapy by decreasing the anti-inflammatory phenotype of macrophages and down-regulation of immunosuppressive proteins in tumor cells | Scientific Reports
Release the B7.1! Anti-PD-L1 breaks PD-L1's grip
Cancers | Free Full-Text | Macrophages Impair TLR9 Agonist Antitumor Activity through Interacting with the Anti-PD-1 Antibody Fc Domain | HTML
PD‐1‐specific “Blocking” antibodies that deplete PD‐1+ T cells present an inconvenient variable in preclinical immunotherapy experiments - Polesso - 2021 - European Journal of Immunology - Wiley Online Library
Bio X Cell - PD1 Antibodies
Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy | Journal for ImmunoTherapy of Cancer | Full Text
Anti-PD-1 Blocking Antibody Inhibits Human Melanoma Xenograft Growth in... | Download Scientific Diagram
PD-1 (EH33) Mouse mAb (IHC-Specific) | Cell Signaling Technology
Human PD-L1 Antibody (PDL1.D1), mAb, Mouse - GenScript
Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastoma | Scientific Reports
Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging | PNAS
Frontiers | PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake | Pharmacology
Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion | Nature Communications
Bio X Cell - InVivoPlus anti-mouse PD-1 (CD279)
A human programmed death-ligand 1-expressing mouse tumor model for evaluating the therapeutic efficacy of anti-human PD-L1 antibodies | Scientific Reports
Anti-PD-1 Neutralizing Antibody
Anti-PD-L1 mIgG1e3 monoclonal antibody | Atezolizumab-based
